Transcriptional regulation by p53 von Beckerman, Rachel, Prives, Carol

Volltext

Three-dimensional evaluation of retinal ganglion cell axon regeneration and pathfinding in whole mouse tissue after injury von Luo, Xueting, Salgueiro, Yadira, Beckerman, Samuel R., Lemmon, Vance P., Tsoulfas, Pantelis, Park, Kevin K.

Volltext

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan von Younossi, Z. M., Tanaka, A., Eguchi, Y., Henry, L., Beckerman, R., Mizokami, M.

Volltext

Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe von Cacoub, P., Buggisch, P., Carrión, J. A., Cooke, G. S., Zignego, A. L., Beckerman, R., Younossi, Z.

Volltext

Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection von Cacoub, P, Buggisch, P, Beckerman, R, Younossi, Z

Volltext

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries von Younossi, Z., Brown, A., Buti, M., Fagiuoli, S., Mauss, S., Rosenberg, W., Serfaty, L., Srivastava, A., Smith, N., Stepanova, M., Beckerman, R.

Volltext

Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies von Smith, N, Beckerman, R

Volltext

Strategies To Overcome Hurdles In Hta Appraisals Amid Limitations Resulting From Single-Arm Trial Data von Xenakis, A, Beckerman, R

Volltext

Difference Between United States And Eu Authorisation Timelines And Time To Reimbursement In The Eu5 von Sun, D, Beckerman, R

Volltext

An Appraisal Of Pcodr’s Decisions and Influence Over the Last 3 Years von Joinnides, M, Beckerman, R

Volltext

Cost-Effectiveness Reviews By Hta Agencies: A Comparison Of Factors Leading To Unfavourable Reviews For Oncology Agents von Smith, N, Beckerman, R

Volltext

In vitro models of axon regeneration von Al-Ali, Hassan, Beckerman, Samuel R., Bixby, John L., Lemmon, Vance P.

Volltext

The Economic and Clinical Burden of Non-Alcoholic Fatty Liver Disease in the United States von Younossi, Z.M, Henry, L, Stepanova, M, Younossi, Y, Racila, A, Hunt, S, Beckerman, R

Volltext

An Analysis of Pricing Premiums Granted Through Submitting Local RCT and Pharmacoeconomics Data in Taiwan von Park, S, Jiang, Y, Sun, D, Beckerman, R

Volltext

An Analysis of the Key Value Drivers for HTA Assessments In Taiwan von Park, S, Jiang, Y, Sun, D, Beckerman, R

Volltext

An Analysis of the Drivers of Pricing Premiums Granted to Innovative Products in Japan von Sun, D, Solon, C, Park, S, Beckerman, R

Volltext

Correlation of HTA Decision Outcomes in France and Germany von Sun, D, Beckerman, R, Bustamante, M.M.D

Volltext

PND89 NEGATIVE HTA RECOMMENDATIONS FOR MEDICINES IN NEUROLOGY THERAPEUTIC AREAS – FOURFOLD HIGHER ODDS IN POLAND COMPARED WITH THE UNITED KINGDOM von Lach, K., Beckerman, R.

Volltext

Correlation of Recent HTA Decisions Between Taiwan and Korea: Implication for Launch Strategies von Sun, D, Park, S, Jiang, Y, Solon, C, Beckerman, R

Volltext

HPR62 Impact of GKV Financial Stabilization Act on Drug Pricing in Germany – Early Experiences of the Reform von Lach, K., Dudzic, M., Beckerman, R.

Volltext